Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MTX-211, an inhibitor of EGFR and PI3K, is used for the therapy of cancer and other diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 96.00 | |
2 mg | In stock | $ 167.00 | |
5 mg | In stock | $ 327.00 | |
10 mg | In stock | $ 497.00 | |
25 mg | In stock | $ 819.00 | |
50 mg | In stock | $ 1,130.00 | |
100 mg | In stock | $ 1,530.00 | |
500 mg | In stock | $ 2,970.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 333.00 |
Description | MTX-211, an inhibitor of EGFR and PI3K, is used for the therapy of cancer and other diseases. |
Synonyms | MTX 211 |
Molecular Weight | 478.33 |
Formula | C20H14Cl2FN5O2S |
CAS No. | 1952236-05-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MTX-211 1952236-05-3 Angiogenesis JAK/STAT signaling PI3K/Akt/mTOR signaling Tyrosine Kinase/Adaptors PI3K EGFR Mol211 MTX211 Phosphoinositide 3-kinase Mol-211 Inhibitor quinazoline derivatives cancer phosphoinositide 3 ' OH kinase family (PIK3) the epidermal growth factor EGFR family ErbB-1 MTX 211 HER1 Mol 211 inhibit Epidermal growth factor receptor inhibitor